Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
Hurabielle C, Pillebout E, Stehlé T, Pagès C, Roux J, Schneider P, Chevret S, Chaffaut C, Boutten A, Mourah S, Basset-Seguin N, Vidal-Petiot E, Lebbé C, Flamant M.
Hurabielle C, et al.
PLoS One. 2016 Mar 1;11(3):e0149873. doi: 10.1371/journal.pone.0149873. eCollection 2016.
PLoS One. 2016.
PMID: 26930506
Free PMC article.